Author's posts
UnitedHealth To Expand Bundled Payments In Medicare Advantage
UnitedHealth Group will expand bundled payments to doctors and hospitals contracted with Medicare Advantage plans effective Jan. 1, 2020.
Centene Commits $100M To Personalized Medicine Research
Centene will contribute $100 million over the next decade to a partnership with Washington University School of Medicine in St. Louis to “accelerate research into treatments for Alzheimer’s disease, breast cancer, diabetes and obesity.”
Big Blue Cross Plans To Open Primary Care Clinics In Texas And Beyond
Health Care Service Corp., the parent of five Blue Cross Blue Shield plans, formed a joint venture with Sanitas USA to open primary care centers in Texas and four other states.
More Telehealth Benefits Coming To Medicare Advantage Plans In 2020
Medicare Advantage plans can offer additional access to virtual doctors in their basic benefit packages under a new rule finalized by the Centers for Medicare & Medicaid Services.
As Congress Zeroes In On Health Costs, Medical Device Makers Ready Their Story
As the new chair of the medical device lobby AdvaMed, Stryker Kevin Lobo is launching an educational campaign of members of Congress on medical devices’ 5.2% share of U.S. medical spending .
Is Walgreens CEO Pessina Opening Up To A Big Merger?
Walgreens Boots Alliance CEO Stefano Pessina says the drugstore chain is “constantly reviewing a certain number of companies.”
As More Rite Aids Close, Walgreens May Accelerate ‘Small Store’ Development
Walgreens is testing a “small store format” while amid a “comprehensive review” to address underperforming retail locations.
Cigna’s Express Scripts PBM To Cap Insulin Costs Amid Drug Price Scrutiny
Cigna and Express Scripts are rolling out a new program to cap out-of-pocket costs for insulin at $25 per 30-day prescriptions.
Cigna’s Express Scripts PBM To Cap Insulin Costs Amid Drug Price Scrutiny
Cigna and Express Scripts are rolling out a new program to cap out-of-pocket costs for insulin at $25 per 30-day prescriptions.
Walgreens: ‘Our Execution Is Lacking’
Walgreens said it will increase an annual cost cutting strategy to “in excess of $1.5 billion” by 2022 from $1 billion.
